2.64MMarket Cap-103P/E (TTM)
0.470High0.431Low12.31KVolume0.450Open0.470Pre Close5.61KTurnover0.31%Turnover RatioLossP/E (Static)5.81MShares2.27052wk High-0.98P/B1.83MFloat Cap0.43152wk Low--Dividend TTM4.02MShs Float619.999Historical High--Div YieldTTM8.26%Amplitude0.431Historical Low0.455Avg Price1Lot Size
Scinai Immunotherapeutics Stock Forum
Scinai Immunotherapeutics Ltd. Sponsored Adr (SCNI) has released an update.
Scinai Immunotherapeutics Ltd. is gaining traction with the development of its nanosized antibodies (NanoAbs), which promise significant clinical and commercial advantages over traditional human monoclonal antibodies. The company has highlighted the potential for NanoAbs in the treatment and prevention of diseases like psoriasis...
PR Newswire· 2 mins ago
3 MINUTES AGO, 7:30 AM EST
VIA PR NEWSWIRE
No comment yet